These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10775753)

  • 1. Antibacterial properties of KwaZulu natal snake venoms.
    Blaylock RS
    Toxicon; 2000 Nov; 38(11):1529-34. PubMed ID: 10775753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanding the neutralization scope of the EchiTAb-plus-ICP antivenom to include venoms of elapids from Southern Africa.
    Sánchez A; Segura Á; Vargas M; Herrera M; Villalta M; Estrada R; Wu F; Litschka-Koen T; Perry MA; Alape-Girón A; León G
    Toxicon; 2017 Jan; 125():59-64. PubMed ID: 27890775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnosis and management of snakebite in dogs--a southern African perspective.
    Leisewitz AL; Blaylock RS; Kettner F; Goodhead A; Goddard A; Schoeman JP
    J S Afr Vet Assoc; 2004 Mar; 75(1):7-13. PubMed ID: 15214688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective study of snake envenomation in 155 dogs from the Onderstepoort area of South Africa.
    Lobetti RG; Joubert K
    J S Afr Vet Assoc; 2004 Dec; 75(4):169-72. PubMed ID: 15830600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibacterial Activity of Venom from the Puff Adder (
    Okumu MO; Eyaan KL; Bett LK; Gitahi N
    Int J Microbiol; 2023; 2023():7924853. PubMed ID: 36908982
    [No Abstract]   [Full Text] [Related]  

  • 6. Development of Equine IgG Antivenoms against Major Snake Groups in Mozambique.
    Guidolin FR; Caricati CP; Marcelino JR; da Silva WD
    PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004325. PubMed ID: 26730709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morbidity and mortality following envenomation by the common night adder (Causus rhombeatus) in three dogs.
    de Cramer KG; van Bart GA; Huberts F
    J S Afr Vet Assoc; 2012 Oct; 83(1):205. PubMed ID: 23327143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of snakebite in Eshowe, KwaZulu-Natal, South Africa.
    Blaylock R
    Toxicon; 2004 Feb; 43(2):159-66. PubMed ID: 15019475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial activity of snake, scorpion and bee venoms: a comparison with purified venom phospholipase A2 enzymes.
    Perumal Samy R; Gopalakrishnakone P; Thwin MM; Chow TK; Bow H; Yap EH; Thong TW
    J Appl Microbiol; 2007 Mar; 102(3):650-9. PubMed ID: 17309613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of bacterial biofilms by the snake venom proteome.
    Khan NA; Amorim FG; Dunbar JP; Leonard D; Redureau D; Quinton L; Dugon MM; Boyd A
    Biotechnol Rep (Amst); 2023 Sep; 39():e00810. PubMed ID: 37559690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of the cytolytic activity of snake venoms from African spitting cobras (Naja spp., Elapidae) and its neutralization by a polyspecific antivenom.
    Méndez I; Gutiérrez JM; Angulo Y; Calvete JJ; Lomonte B
    Toxicon; 2011 Nov; 58(6-7):558-64. PubMed ID: 21924279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Snake venomics of Bitis species reveals large intragenus venom toxin composition variation: application to taxonomy of congeneric taxa.
    Calvete JJ; Escolano J; Sanz L
    J Proteome Res; 2007 Jul; 6(7):2732-45. PubMed ID: 17559253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of a cell-based assay to differentiate between the cytotoxic effects of elapid snake venoms.
    Kalam Y; Isbister GK; Mirtschin P; Hodgson WC; Konstantakopoulos N
    J Pharmacol Toxicol Methods; 2011; 63(2):137-42. PubMed ID: 20849965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biochemical variations of West African snake venoms].
    Boche J; Chippaux JP; Courtois B
    Bull Soc Pathol Exot Filiales; 1981; 74(3):356-66. PubMed ID: 7285271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Snake venoms promote stress-induced senescence in human fibroblasts.
    Lewinska A; Bocian A; Petrilla V; Adamczyk-Grochala J; Szymura K; Hendzel W; Kaleniuk E; Hus KK; Petrillova M; Wnuk M
    J Cell Physiol; 2019 May; 234(5):6147-6160. PubMed ID: 30317566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the Antimicrobial Activity of Few Saudi Arabian Snake Venoms.
    Al-Asmari AK; Abbasmanthiri R; Abdo Osman NM; Siddiqui Y; Al-Bannah FA; Al-Rawi AM; Al-Asmari SA
    Open Microbiol J; 2015; 9():18-25. PubMed ID: 26668657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Antifungal Activity of
    Kuna E; Bocian A; Hus KK; Petrilla V; Petrillova M; Legath J; Lewinska A; Wnuk M
    Toxins (Basel); 2020 Aug; 12(8):. PubMed ID: 32759763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unexpected lack of specialisation in the flow properties of spitting cobra venom.
    Avella I; Barajas-Ledesma E; Casewell NR; Harrison RA; Rowley PD; Crittenden E; Wüster W; Castiglia R; Holland C; van der Meijden A
    J Exp Biol; 2021 Apr; 224(Pt 7):. PubMed ID: 33827968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unexpected lack of specialisation in the flow properties of spitting cobra venom.
    Avella I; Barajas-Ledesma E; Casewell NR; Harrison RA; Rowley PD; Crittenden E; Wüster W; Castiglia R; Holland C; van der Meijden A
    J Exp Biol; 2021 Apr; 224(7):. PubMed ID: 34424974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross neutralization of dangerous snake venoms from Africa and the Middle East using the VACSERA polyvalent antivenom. Egyptian Organization for Biological Products & Vaccines.
    Seddik SS; Wanas S; Helmy MH; Hashem M
    J Nat Toxins; 2002 Dec; 11(4):329-35. PubMed ID: 12503876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.